Proteomics in obesity research

Proteomics - Clinical Applications

Volumn 3, Issue 2, 2009, Pages 263-278

  Barceló Batllori, Sílvia ^a   Gomis, Ramon ^b,c  

^a INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Adipocyte; Adipose tissue; Obesity; Proteomics; Secretome

Indexed keywords

ACYL COENZYME A DESATURASE; ADIPONECTIN; CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; INSULIN; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOL BINDING PROTEIN 4; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; TUNGSTEN DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE; BARIATRIC SURGERY; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL SECRETION; CLINICAL TRIAL; DIABETES MELLITUS; DRUG MECHANISM; ENERGY EXPENDITURE; ENVIRONMENTAL FACTOR; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; HUMAN; HYDROPHOBICITY; INSULIN RESISTANCE; LIPID METABOLISM; MASS SPECTROMETRY; MORBIDITY; MORTALITY; NONHUMAN; OBESITY; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUALITY OF LIFE; REVIEW; RISK FACTOR; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 65549110896     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800178     Document Type: Review

References (118)

1. James, W. P. T., Haslam, D. W., Obesity: Preventing and managing the global epidemic. The Lancet 2005, 366, 1197-1209.
2. Odgen, C. L., Carrol, M. D., Curtin, L. R., McDowell, M. A. et al., Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295, 1549-1555.
3. Friedman, J. M., A war on obesity, not the obese. Science 2003, 299, 856-859.
4. Pi-Sunyer, X., A clinical view of the obesity problem. Science 2003, 299, 859-860.
5. Kopelman, P. G., Obesity as a medical problem. Nature 2000, 404, 635-643.
6. Hill, J. O., Wyatt, H. R., Reed, G. W., Peters, J. C., Obesity and the environment: Where do we go from here? Science 2003, 299, 853-855.
7. Speakman, J. R., Obesity: The integrated roles of environment and genetics. J. Nutr. 2004, 134, 2090S-2105S.
8. Montague, C. T., Farooqi, I. S., Whitehead, J. P., Soos, M. A. et al., Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387, 903-908.
9. Clément, K., Vaisse, C., Lahlou, N., Cabrol, S. et al., A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature, 1998, 392, 398-401.
10. Krude, H., Biebermann, H., Luck, W., Horn, R. et al., Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998, 19, 155-157.
11. Vaisse, C., Clement, K., Guy-Grand, B., Froguel, P., A frame-shift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet. 1998, 20, 113-114.
12. Yeo, G. S., Farooqi, I. S., Aminian, S., Halsall, D. J. et al., A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet. 1998, 20, 111-112.
13. Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E. et al., A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316, 889-894.
14. Mutch, D. M., Clement, K., Unraveling the genetics of human obesity. PLosGen 2006, 2, 1956-1963.
15. Emilson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S. et al., Genetics of gene expression and its effect on disease. Nature 2008, 452, 423-428.
16. Rankinen, T., Zuberi, A., Chagnon, Y. C., Weisnagel, S. J. et al., The human obesity gene map: The 2005 update. Obesity 2006, 4, 529-644.
17. Marx, J., Cellular warriors at the battle of the bulge. Science 2003, 299, 846-849.
18. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. et al., Central nervous system control of food intake and body weight. Nature 2006, 443, 289-295.
19. Spiegelman, B. M., Flier, J. S., Obesity and the regulation of energy balance. Cell 2001, 104, 531-543.
20. Friedman, J. M., Modern science versus the stigma of obesity. Nature 2004, 10, 563-569.
21. Guilherme, A., Virbasius, J. V., Puri, V., Czech, M. P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. 2008, 9, 367-377.
22. Lowell, B. B., Spiegelman, B. M., Towards a molecular understanding of adaptative thermogenesis. Nature 2000, 404, 652-660.
23. Frühbeck, G., Gomez-Ambrosi, J., Muruzabal, F. J., Burrell, M. A., The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Met. 2001, 280, E827-E847.
24. Cannon, B., Nedergaard, J., Brown adipose tissue: Function and physiological significance. Physiol. Rev. 2004, 84, 277-359.
25. Nedergaard, J., Bengtsson, T., Cannon, B., Unexpected evidence for active brown adipose tissue in adult humans. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E444-E452.
26. Badmana, M. K., Flier, J. S., The adipocyte as an active participant in energy balance and metabolism. Gatroenterology 2007, 132, 2103-2115.
27. Rosen, E. D., MacDougald, O. A., Adipocyte differentiation from the inside out. Nat. Rev. 2006, 7, 885-896.
28. Farmer, S. R., Transcriptional control of adipocyte formation. Cell Metab. 2006, 4, 263-273.
29. Seale, P., Kajimura, S., Yang, W., Chin, S. et al., Transcriptional control of brown fat determination by PRDM16. Cell Metab. 2007, 6, 38-54.
30. Hansen, J. B., Kristiansen, K., Regulatory circuits controlling white versus brown adipocyte differentiation. Biochem. J. 2006, 398, 153-168.
31. Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S. et al., Dynamics of fat cell turnover in humans. Nature 2008, 453, 783-787.
32. Friedman, J. M., The function of leptin in nutrition, weight, and physiology. Nutr. Rev. 2002, 60, S1-S14.
33. Trayhurn, P., Wood, I. S., Signalling role of adipose tissue: Adipokines and inflammation in obesity. Biochem. Soc. Trans. 2005, 33, 1078-1081.
34. Tilg, H., Moschen, A. R., Adipocytokines: Mediators linking adipose tissue, inflammation and immunity. Nature 2006, 6, 771-783.
35. Ahima, R. S., Osei, S. Y., Adipokines in obesity. Front Horm Res. 2008, 36, 182-197.
36. Wellen, K. E., Hotamisligil, G. S., Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 2003, 12, 1785-1788.
37. Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M. et al., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112, 1796-1808.
38. Xu, H., Barnes, G. T., Yang, Q., Tan, G. et al., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112, 1821-1830.
39. Neels, J. G., Olefsky, J. M., Inflamed fat: What starts the fire? J. Clin. Invest. 2006, 116, 33-35.
40. Steen, H., Mann, M., The ABC's (and XYZ's) of peptide sequencing. Nat. Rev. 2004, 6, 699-711.
41. Nesvizhskii, A., Vitek, O., Aebersold, R., Analysis and validation of proteomic data generated by tandem mass spectrometry. Nature Meth. 2007, 4, 787-797.
42. Reinders, J., Lewandrowski, U., Moebius, J., Wagner, Y. et al., Challenges in mass spectrometry-based proteomics. Proteomics 2004, 12, 3686-3703.
43. Lim, M. S., Elenitoba-Johnson, K. S. J., Proteomics in pathology research. Lab. Investig. 2004, 84, 1227-1244.
44. Baldwin, M. A., Protein identification by mass spectrometry: Issues to be considered. Mol. Cell. Proteomics 2004, 3, 1-9.
45. Blow N., Mass spectrometry and proteomics: Hitting the mark. Nat. Meth. 2008, 5, 741-747.
46. Dunn, M. J., Corbett, J. M., Two-dimensional polyacrylamide gel electrophoresis. Methods Enzymol. 1996, 271, 177-203.
47. Görg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
48. Carrette, O., Burkhard, P. R., Sanchez, J. C., Hochstrasser, D. F., State-of-the-art two-dimensional gel electrophoresis: A key tool of proteomics research. Nat. Protoc. 2006, 1, 812-823.
49. Unlu, M., Morgan, M. E., Minden, J. S., Difference gel electrophoresis: A single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
50. Marouga, R., David, S., Hawkins, E., The development of the DIGE system: 2-D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 2005, 382, 669-678.
51. Karp, N. A., Kreil, D. P., Lilley, K. S., Determining a significant change in protein expression with DeCyder™ during a pairwise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4, 1421-1432.
52. Washburn, M. P., Wolters, D., Yates, J. R., Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotech. 2001, 19, 242-247.
53. Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
54. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
55. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 2004, 3, 1154-1169.
56. Pierce, A., Unwin, R. D., Evans, C. A., Griffiths, S. et al., Eight-channel iTRAQ enables comparison of the activity of 6 leukaemogenic tyrosine kinases. Mol. Cell. Proteomics 2008, 7, 853-863.
57. Lu, P., Vogel, C., Wang, R., Yao, X. et al., Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat. Biotechnol. 2007, 25, 117-124.
58. Mallick, P., Schirle, M., Chen, S. S., Flory, M. R. et al., Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 2007, 25, 125-131.
59. Bergeron, J. J., Hallett, M., Peptides you can count on. Nat. Biotechnol. 2007, 25, 61-62.
60. Rifai, N., Gillette, M. A., Carr, S. A., Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24, 971-983.
61. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J. et al., Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002, 359, 572-577.
62. Zhu, H., Bilgin, M., Bangham, R., Hall, D. et al., Global analysis of protein activities using proteome chips. Science 2001, 293, 2101-2105.
63. Nettikadan, S., Radke, K., Johnson, J., Xu, J. et al., Detection and quantification of protein biomarkers from fewer than 10 cells. Mol. Cell. Proteomics 2006, 5, 895-901.
64. Lueking, A., Cahill, D. J., Müllner, S., Protein biochips: A new and versatile platform technology for molecular medicine. Drug Disc. Today 2005, 10, 789-794.
65. Lv, L. L., Liu, B. C., High-throughput antibody microarrays for quantitative proteomic analysis. Expert Rev. Proteomics 2007, 4, 505-513.
66. Reid, J. D., Parker, C. E., Borchers, C. H., Protein arrays for biomarker discovery. Curr. Opin. Mol. Ther. 2007, 9, 216-221.
67. Sanchez, J. C., Chiappe, D., Converset, V., Hoogland, C. et al., The mouse SWISS-2-D PAGE database: A tool for proteomics study of diabetes and obesity. Proteomics 2001, 1, 136-163.
68. Lanne, B., Potthast, F., Höglund, A., Brockenhuus von Löwenhielm, H. et al., Thiourea enhances mapping of the proteome from murine white adipose tissue. Proteomics 2001, 1, 819-828.
69. Cortón, M., Villuendas, G., Botella, J. I., San Millán, J. L. et al., Improved resolution of the human adipose proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide. Proteomics 2004, 4, 438-441.
70. Cortón, M., Botella-Carretero, J. I., López, J. A., Camafeita, E. et al., Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum. Reprod.. 2008, 23, 651-661.
71. Celis, J. E., Moreira, J. M., Cabezón, T., Gromov, P. et al., Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: Toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol. Cell. Proteomics 2005, 4, 492-522.
72. Adachi, J., Kumar, C., Zhang, Y., Mann, M., In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics. Mol. Cell. Proteomics 2007, 6, 1257-1273.
73. Brasaemle, D. L., Dolios, G., Shapiro, L., Wang, R., Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279, 46835-46842.
74. Aboulaich, N., Vainonen, J. P., Stralfors, P., Vener, A. V., Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes. Biochem. J. 2004, 383, 237-248.
75. Guilherme, A., Emoto, M., Buxton, J. M., Bose, S. et al., Perinuclear localization and insulin responsiveness of GLUT4 requires cytoskeletal integrity in 3T3-L1 adipocytes. J. Biol. Chem. 2000, 275, 38151-38159.
76. Takahshi, H., Oh-Ishi, M., Shimizu, H., Mori, M. et al., Detection and identification of subcutaneous adipose tissue protein related to obesity in New Zealand obese mouse. Endocrinol. J. 2001, 48, 205-211.
77. Sanchez, J.-C., Converset, V., Nolan, A., Schmid, G. et al., Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice. Proteomics 2003, 3, 1500-1520.
78. Schmid, G. M., Converset, V., Walter, N., Sennitt, M. V. et al., Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 2004, 4, 2270-2282.
79. Blüher, M., Wilson-Fritch, L., Leszky, J., Laustsen, P. G. et al., Role of insulin action and cell size on protein expression patterns in adipocytes. J. Biol. Chem. 2004, 23, 31902-31909.
80. Barceló-Batllori, S., Corominola, H., Claret, M., Canals, I. et al., Target identification of the novel anti-obesity agent tungstate in adipose tissue from obese rats. Proteomics 2005, 5, 4927-4935.
81. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M. et al., Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004, 114, 1752-1761.
82. Blüher, M., Michael, M. D., Peroni, O. D., Ueki, K. et al., Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell 2002, 3, 25-38.
83. Jernas, M., Palming, J., Sjoholm, K., Jennische, E. et al., Separation of human adipocytes by size: Hypertrophic fat cells display distinct gene expression. FASEB J. 2006, 20, E832-E839.
84. Grimsrud, P. A., Picklo, M. J., Griffin, T. J., Bernlohr, D. A., Carbonylation of adipose proteins in obesity and insulin resistance: Identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol. Cell. Proteomics 2007, 6, 624-637.
85. Choi, K.-L., Wang, Y., Tse, C. A., Lam, K. S. L. et al., Proteomic analysis of adipocyte differentaition: Evidence that α2 macroglobulin is involved in the adipose conversion of 3T3 L1 preacipocytes. Proteomics 2004, 4, 1840-1848.
86. Welsh, G. I., Griffiths, M. R., Webster, K. J., Page, M. J. et al., Proteome analysis of adipogenesis. Proteomics 2004, 4, 1042-1051.
87. Wilson-Fritch, L., Burkart, A., Bell, G., Mendelson, K. et al., Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol. Cell. Biol. 2003, 23, 1085-1094.
88. Lee, H. K., Lee, B.-H., Park, S.-A., Kim, C.-W., The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two dimensional gel electrophoresis. Proteomics 2006, 6, 1223-1229.
89. DeLany, J. P., Floyd, Z. E., Zvonic, S., Smith, A. et al., Proteomic analysis of primary cultures of human adipose-derived stem cells. Mol. Cell. Proteomics 2005, 4, 731-740.
90. Chouchane, L., Danguir, J., Beji, C., Bouassida, K. et al., Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int. J. Obes. Relat. Metab. Disord. 2002, 25, 462-466.
91. Kratchmarova, I., Kalume, D. E., Blagoev, B., Scherer, P. E. et al., A proteomic approach for identification of secreted proteins during the differentiation of 3T3-L1 preadipocytes to adipocytes. Mol. Cell. Proteomics 2002, 1, 213-222.
92. Wang, P., Marimana, E., Keijer, J., Bouwmana, F. et al., Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell. Mol. Life Sci. 2004, 61, 2405-2417.
93. Wang, P., Keijer, J., Bunschoten, A., Bouwman. F. et al., Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: A role for transcriptional regulation of processing. Diabetologia 2006, 49, 2453-2462.
94. Chen, X., Cushman, S. W., Pannell, L. K., Hess, S., Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2-D liquid chromatography-MS/MS approach. J. Prot. Res. 2005, 4, 570-577.
95. Lim, J.-L., Sherling, D., Teo, C. F., Hausman, D. B. et al., Defining the regulated secreted proteome of rodent adipocytes upon the induction of insulin resistance. J. Proteome Res. 2008, 7, 1251-1263.
96. Zvonic, S., Lefevre, M., Kilroy, G., Floyd, Z. E. et al., Secretome of primary cultures of human adipose-derived stem cells. Mol. Cell. Proteomics 2007, 6, 18-28.
97. Alvarez-Llamas, G., Szalowska, E., de Vries, M. P., Weening, D. et al., Characterization of the human visceral adipose tissue secretome. Mol. Cell. Proteomics 2007, 6, 589-600.
98. Maury, E., Ehala-Aleksejev, K., Guiot, Y., Detry, R. et al., Adipokines oversecreted by omental adipose tissue in human obesity. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E656-E665.
99. Van Gaal, L. F., Mertens, I. L., DeBlock, C. E., Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444, 875-880.
100. Klimcakova, E., Moro, C., Mazzucotelli, A., Lolmède, K. et al., Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists. Biochem. Biophs. Res. Commun. 2007, 358, 897-902.
101. Bays, H. E. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes Res. 2004, 12, 1197-1211.
102. Bessesen, D. H., Update on Obesity. J. Clin. Endocrinol. Metab. 2008, 93, 2027-2034.
103. fat/fat mice: Quantitative proteomics of serum. Obes. Res. 2004, 12, 1179-1188.
104. Che, F.-Y., Yuan, Q., Kalinina, E., Fricker, L. D., Peptidomics of Cpefat/fat mouse hypothalamus. J. Biol. Chem. 2005, 280, 4451-4461.
105. Claret, M., Corominola, H., Canals, I., Saura, J. et al., Tung-state decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 2005, 146, 4362-4369.
106. Barceló-Batllori, S., Kalko, S. G., Esteban, Y., Moreno, S. et al., Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol. Cell. Proteomics 2008, 7, 378-393.
107. Edvardsson, U., Brockenhuus, H., Panfilov, O., Nyström, A. C. et al., Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisomes proliferator-activated receptor activators. Proteomics 2003, 3, 468-478.
108. Kersten, S., Peroxisome proliferator activated receptors and obesity. Eur. J. Pharmacol. 2002, 440, 223-234.
109. Morinigo, R., Casamitjana, R., Delgado, S., Lacy, A. et al., Insulin resistance, inflamation and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007, 30, 1906-1908.
110. Brandacher, G., Golderer, G., Kienzl, K., Werner, E. R. et al., Potential applications of global protein expression analysis (proteomics) in morbid obesity and bariatric surgery. Obes. Surg. 2008, 18, 905-910.
111. Maris, M., Overbergh, L., Mathieu, C., Type 2 diabetes: Gaining insight into the disease process using proteomics. Proteomics Clin. Appl. 2008, 2, 312-326.
112. Wang, X. L., Fu, A., Spiro, C., Lee1, H. C., Clinical application of proteomics approaches in vascular diseases. Proteomics Clin. Appl. 2008, 2, 238-250.
113. Oh-Ishi, M., Ueno, T., Maeda, T., Proteomic method detects oxidatively induced protein carbonyls in muscles of a diabetes model Otsuka Long-Evans tokusim fatty (OLEFT) rat. Free Radic. Biol. Med. 2003, 34, 11-22.
114. Edvardsson, U., Alexandersson, M., Brockenhuus von Löwenhielm, H., Nyström, A. C. et al., A proteome analysis of livers from obese (ob/ob) mice treated with the peroxisome proliferator WY14,643. Electrophoresis 1999, 20, 935-942.
115. Douette, P., Gerkens, P., Navet, R., Leprince, P. et al., Uncoupling protein 1 affects the yeast mitoproteome and oxygen free radical production. Free Radical Biol. Med. 2006, 40, 303-315.
116. Szalowska, E., van Hijum, S. A. F. T., Roelofsen, H., Hoek, A. et al., Fractional factorial design for optimization of the SELDI protocol for human adipose tissue culture media. Biotechnol. Prog. 2007, 23, 217-224.
117. Hittel, D. S., Hathout, Y., Hoffman, E. P., Houmard, J. A., Proteome analysis of skeletal muscle from obese and morbidly bese women. Diabetes 2005, 54, 1283-1288.
118. Dayarathna, M. K. D. R., Hancock, W. S., Hincapie, M., A two step fractionation approach for plasma proteomics using immunodepletion of abundant proteins and multi-lectin affinity chromatography: Application to the analysis of obesity, diabetes, and hypertension diseases. J. Sep. Sci. 2008, 31, 1156-1166.